| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1052-3057(11)80015-7 |
| P698 | PubMed publication ID | 26487521 |
| P2093 | author name string | N Futrell | |
| C H Millikan | |||
| P2860 | cites work | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 |
| Anticardiolipin antibodies in rheumatoid arthritis | Q28302463 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus | Q33393531 | ||
| Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases | Q33408807 | ||
| Risk factors for thrombosis in lupus patients | Q33417102 | ||
| Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study | Q33424619 | ||
| Cerebral infarct, TIA, and lupus inhibitor | Q33446409 | ||
| The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus | Q33446426 | ||
| Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients | Q33447381 | ||
| Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus | Q33450672 | ||
| Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. | Q33451037 | ||
| Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 | ||
| Cerebral infarction associated with lupus anticoagulants--preliminary report | Q33478161 | ||
| Thrombosis in patients with the lupus anticoagulant | Q33486691 | ||
| Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity | Q70385967 | ||
| "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia | Q70425310 | ||
| Lupus anticoagulant in pregnancy | Q70474166 | ||
| The neurological manifestations of systemic lupus erythematosus | Q70861096 | ||
| Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations | Q71466748 | ||
| Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis | Q71505016 | ||
| Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis | Q71599044 | ||
| Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas | Q71655869 | ||
| Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation | Q72451284 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease | Q33490122 | ||
| Reduced prostacyclin activity in systemic lupus erythematosus | Q33552720 | ||
| Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal | Q33556284 | ||
| Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies | Q33557638 | ||
| Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus | Q33562091 | ||
| Recurrent ischemic attacks in two young adults with lupus anticoagulant | Q34259693 | ||
| The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level | Q39289964 | ||
| Cardiovascular manifestations of systemic lupus erythematosus: current perspective | Q39367850 | ||
| Significance of the lupus anticoagulant | Q39589345 | ||
| Cerebrovascular ischemia associated with lupus anticoagulant | Q39593049 | ||
| The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies | Q39596940 | ||
| Clinically significant valvular heart disease in systemic lupus erythematosus | Q39616818 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| Central nervous system involvement in SLE. Diagnostic profile and clinical features | Q40647064 | ||
| Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity | Q40694833 | ||
| A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke | Q40902718 | ||
| CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. | Q40971202 | ||
| Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome | Q41238775 | ||
| Cranial computed tomography in the diagnosis of systemic lupus erythematosus | Q41477906 | ||
| Circulating coagulation inhibitors in the acquired immunodeficiency syndrome | Q43755246 | ||
| Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis | Q44440961 | ||
| Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus | Q44875225 | ||
| Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis | Q45282938 | ||
| A clinical and pathologic study of cerebrovascular disease in patients with systemic lupus erythematosus | Q48313469 | ||
| The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients | Q48369404 | ||
| Embolic stroke complicating systemic lupus erythematosus | Q48464615 | ||
| Cerebral Angiography in Vasculitis Affecting the Nervous System | Q48695215 | ||
| Controlled Trial of Dipyridamole in Cerebral Vascular Disease | Q49168371 | ||
| Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients | Q49209737 | ||
| Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosus | Q53804990 | ||
| A chlorpromazine-induced inhibitor of blood coagulation | Q67647448 | ||
| Renal vein thrombosis, nephrotic syndrome, and systemic lupus erythematosus: an association in four cases | Q67805779 | ||
| Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group | Q68910126 | ||
| Anticardiolipin antibodies in patients with rheumatic diseases | Q69198661 | ||
| Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant | Q69211431 | ||
| IgG class anti-cardiolipin antibody as a possible marker for evaluating fetal risk in patients with systemic lupus erythematosus | Q69270196 | ||
| Detection of antiphospholipid autoantibody in systemic lupus erythematosus is temperature-dependent | Q69427587 | ||
| Headache, mental status changes, and death in a 36-year-old woman with lupus | Q69481704 | ||
| Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus | Q69605421 | ||
| Anticardiolipin antibodies in systemic lupus erythematosus | Q69743149 | ||
| The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA | Q69937135 | ||
| Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases | Q69952447 | ||
| Obstetric complications associated with the lupus anticoagulant | Q69970475 | ||
| Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions | Q70008577 | ||
| Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant | Q70281811 | ||
| Association of lupus anticoagulant with antibody against phosphatidylserine | Q70315632 | ||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| anticoagulant | Q215118 | ||
| P304 | page(s) | 9-20 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Journal of Stroke and Cerebrovascular Diseases | Q15762579 |
| P1476 | title | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant | |
| P478 | volume | 1 |
| Q40971477 | Stroke is an emergency | cites work | P2860 |
Search more.